A historical perspective on the specific activity of radiopharmaceuticals: What have we learned in the 35years of the ISRC?

Nuclear Medicine and Biology

Volumn 40, Issue 3, 2013, Pages 314-320

  Lapi, Suzanne E ^a   Welch, Michael J ^a  

^a WASHINGTON UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

Carbon 11; Fluorine 18; Specific activity

Indexed keywords

2 BETA CARBOMETHOXY 3 BETA (4 FLUOROPHENYL)TROPANE F 18; 2 FLUOROETHANOL F 18; 8 AZIDO 5,6 DIHYDRO 5 METHYL 6 OXO 4H IMIDAZO[1,5 A][1,4]BENZODIAZEPINE 3 CARBOXYLIC ACID ETHYL ESTER C11; CARBON 11; CARBON COBALT CHLORIDE C 11; CARBON FORMALDEHYDE C 11; FLUORINE 18; FLUORINE ARGINYLGLYCYLASPARTIC ACID F 18; FLUORINE DESMETHOXYFALLYPRIDE F 18; FLUOROBENZOATE F 18; RADIOPHARMACEUTICAL AGENT; UNCLASSIFIED DRUG;

ARTICLE; BIOTECHNOLOGICAL PRODUCTION; CARBON SOURCE; DATA BASE; EFFECTIVE SPECIFIC ACTIVITY; GAS CHROMATOGRAPHY; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; HISTORY OF MEDICINE; ISOTOPE DILUTION ASSAY; LABORATORY AUTOMATION; MOLECULAR IMAGING; NEUROIMAGING; RADIATION MEASUREMENT; RADIOACTIVITY; RADIOCHEMISTRY; RECEPTOR BINDING; SPECIFIC ACTIVITY; SYNTHESIS;

CONGRESSES AS TOPIC; CONTRAST MEDIA; DATABASES, PHARMACEUTICAL; HISTORY, 20TH CENTURY; HISTORY, 21ST CENTURY; MOLECULAR IMAGING; RADIOCHEMISTRY; RADIOPHARMACEUTICALS;

EID: 84875272121     PISSN: 09698051     EISSN: 18729614     Source Type: Journal    
DOI: 10.1016/j.nucmedbio.2012.12.010     Document Type: Article

References (39)

1. Fowler J.S., et al. Serotonin-C-11 - tracer for pulmonary endothelial extraction of serotonin. J Label Compd Radiopharm 1977, 13(2):194-195.
2. Maziere M., Berger G., Comar D. Optimization of C-11 labeling of radiopharmaceuticals - C-11 clomipramine as an example. J Label Compd Radiopharm 1977, 13(2):196-197.
3. Reiffers S., et al. Synthesis of C-11 labeled Dopa/ Dopa. J Label Compd Radiopharm 1977, 13(2):198-199.
4. Vaalburg W., et al. Preparation of C-11 labeled 17alpha-ethynylestradiol. J Label Compd Radiopharm 1977, 13(2):200-201.
5. Wieland B.W., et al. Development of cyclotron targetry and remote radiochemical techniques for continuous large-scale production of C-11-labeled amino-acids. J Label Compd Radiopharm 1977, 13(2):202.
6. Washburn L.C., et al. C-11-labeled amino-acids as agents for tumor and pancreas visualization. J Label Compd Radiopharm 1977, 13(2):203.
7. Tewson T.J., Welch M.J. Preparation and preliminary biodistribution of no carrier added F-18 fluoroethanol. J Nucl Med 1980, 21(6):559-564.
8. Casella V.R., Ido T., Wolf A.P. Production of anhydrous F-18 for nuclear-medicine. J Label Compd Radiopharm 1977, 13(2):209.
9. Lemire A., Schroader K.J., Reed M.F. Preparation of F-18-labeled tobacco-smoke. J Label Compd Radiopharm 1977, 13(2):211.
10. Dekleijn J.P., et al. Labeling with reactor produced F-18.3. polymer supported F-18 as a fluorinating agent. Int J Appl Radiat Isot 1977, 28(6):591-594.
11. Larsen P., et al. Synthesis of [C-11]iodomethane by iodination of [C-11]methane. Appl Radiat Isot 1997, 48(2):153-157.
12. 2. J Label Compd Radiopharm 1995, 37:76-78.
13. 18F]Fluoromethylated 1-phenyl-3-(aminomethyl)pyrroles and 7-azaindole analogue 1997.
14. Sarkadi E., Elsinga P.H., Visser T.J., Luurtsema G., Vallburg W., Kovacs Z. The search for carrier carbon during [11C]COCl2 production 1997.
15. Holschbach M., Schirrmacher R., Solbach C., Hamkens W., Coenen H.H. Selective and high-yield N.C.A. 11C-methylation of polyfunctional molecules using different alkylation agents and optimized reaction conditions 1997.
16. Bonasera T.A., Lidstrom P., Lu L., Bergstrom M., Langstrom B. Synthesis and in vitro autoradiography of two 11C labelled antiprogestins: RU38486 and ZK 98299 1997.
17. 18F]CFT 1997.
18. Bergman J., Solin O. Fluorine-18-labeled fluorine gas for synthesis of tracer molecules. Nucl Med Biol 1997, 24(7):677-683.
19. Kessler L. Development of novel ligands for PET imaging of metabotropic glutamate receptor subtype 5 2006, Switzerland.
20. Sasaki M., et al. An improved automated synthesis and in vivo evaluation of PET radioligand for serotonin re-uptake sites: [11C]McN5652X. Kaku Igaku 1996, 33(12):1319-1327.
21. Noguchi J., Suzuki K. Automated synthesis of the ultra high specific activity of [C-11]Ro15-4513 and its application in an extremely low concentration region to an ARG study. Nucl Med Biol 2003, 30(3):335-343.
22. Zhang M.R., et al. Visualization of early infarction in rat brain after ischemia using a translocator protein (18kDa) PET ligand [(11)C]DAC with ultra-high specific activity. Neuroimage 2011, 54(1):123-130.
23. Zhang M.R., et al. Imaging of the translocator protein (18kDa) in rat brain after ischemia using [(11)C]DAC with ultra-high specific activity. Synapse 2010, 64(6):488-493.
24. Andersson J., Truong P., Halldin C. An increased specific radioactivity of [(11)C]Hcn was obtained using in-target produced [(11)C]methane. J Label Compd Radiopharm 2005, 48:S108.
25. Turton D.R., Yau K. HPLC UV detector response to radioactivity in the analysis of pet radiotracers. J Label Compd Radiopharm 2005, 48:S139.
26. Tu Z., et al. A novel F-18 labeled sigma(2) receptor ligand for imaging breast cancer. J Label Compd Radiopharm 2005, 48:S280.
27. de Vries E.F.J., et al. The effect of p-glycoprotein (Pgp) modulation on specific uptake of substituted [(18)F]MPPF derivatives. J Label Compd Radiopharm 2005, 48:S1.
28. Zeng F., et al. Synthesis and evaluation of (18)F-labeled FIMPYD as a pet imaging agent for beta-amyloid plaques. J Label Compd Radiopharm 2005, 48:S41.
29. Wuest F., et al. Synthesis and characterization of [(18)F]Mcl-322 as a potential PET radiotracer for imaging the dopamine transporter. J Label Compd Radiopharm 2005, 48:S204.
30. Saigal N., et al. Towards a metabolically stable fluorine-18 PET radiotracer for serotonin 5HT(1a) receptors. J Label Compd Radiopharm 2005, 48:S85.
31. Blagoev M., et al. Radiosynthesis and evaluation of (18)F-Agc393 as a biological marker of beta-amyloid deposits. J Label Compd Radiopharm 2005, 48:S319.
32. Horvath G.M., Popkov A., Elsinga P.H. Modifications in synthesis of [(18)F]-peptides and application to substance P. J Label Compd Radiopharm 2005, 48:S212.
33. Kim H.W., et al. Synthesis of [(18)F]fluoromethylspiperone ([(18)F]FMSP) via [(18)F]fluoromethyl triflate synthesis. J Label Compd Radiopharm 2005, 48:S231.
34. Pichika R., et al. Nicotinic alpha 4 beta 2 receptor imaging agents - part II. Synthesis and biological evaluation of 2-[F-18]fluoro-3-[2-((S)-3-pyrrolinyl)methoxy]pyridine (F-18-nifene) in rodents and imaging by PET in nonhuman primate. Nucl Med Biol 2006, 33(3):295-304.
35. Grunder G., et al. Quantification of D-2-like dopamine receptors in the human brain with F-18-desmethoxyfallypride. J Nucl Med 2003, 44(1):109-116.
36. Solin O., et al. Synthesis and characterization of a potent, selective, radiolabeled substance-P antagonist for NK1 receptor quantitation: ([F-18]SPA-RQ). Mol Imaging Biol 2004, 6(6):373-384.
37. Conti P.S., et al. F-18-labeled RGD peptide: initial evaluation for imaging brain tumor angiogenesis. Nucl Med Biol 2004, 31(2):179-189.
38. Satyamurthy N., et al. Tantalum [18O]water target for the production of [18F]fluoride with high reactivity for the preparation of 2-deoxy-2-[18F]fluoro-D-glucose. Mol Imaging Biol 2002, 4(1):65-70.
39. Fuchtner F., et al. Factors affecting the specific activity of [18F]fluoride from a [18O]water target. Nuklearmedizin 2008, 47(3):116-119.